NCT02354599View on ClinicalTrials.gov

Single-Dose Study of MT203

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

MT203 80 mg or matching Placebo

MT203 80 mg or matching placebo injection

DRUG

MT203 150mg or matching Placebo

MT203 150mg or matching placebo injection

DRUG

MT203 300 mg or matching placebo

MT203 300 mg or matching placebo injection

Trial Locations (1)

Unknown

Kagoshima

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY